Charming Medical (Nasdaq: MCTA) announced full exercise of the underwriters' 15% over-allotment option, adding 240,000 Class A ordinary shares at the public offering price of $4.00 per share. The over-allotment generated gross proceeds of $0.96 million, bringing aggregate gross proceeds from the initial public offering to approximately $7.36 million before underwriting discounts and offering expenses.
The company's Class A ordinary shares began trading on the Nasdaq Capital Market on October 21, 2025. The company said it intends to use net proceeds for business expansion, strategic investments and acquisitions, research and development, and general working capital.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.